Feng Hong

Feng Hong serves as the Senior Director and Head of Clinical Laboratory Operations in Precision Medicine at Regeneron since August 2023. Previously, Feng held positions as Senior Director of Clinical Biomarker Operations at Turning Point Therapeutics from January 2022 to August 2023 and Director of Clinical Biospecimen Management at BioMarin Pharmaceutical Inc. from September 2015 to January 2022. With a background in managing clinical trial samples and supporting translational research, Feng's experience spans multiple roles in various pharmaceutical companies, including Amgen, Amphastar Pharmaceuticals, and Gentris LLC, among others. Education includes a Ph.D. in Environmental Science from the University of Cincinnati, an MS Equivalent in Cell Biology from the University of Cincinnati College of Medicine, and a B.S. in Microbiology from Fudan University.